2015 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
12/02/15Proteon Therapeutics to Present at the Oppenheimer 26th Annual Healthcare Conference December 9thPrinter Friendly Version
11/13/15Proteon Therapeutics to Present at the Stifel 2015 Healthcare Conference on November 17thPrinter Friendly Version
11/12/15Proteon Therapeutics Announces Third Quarter 2015 Financial ResultsPrinter Friendly Version
11/09/15Proteon Therapeutics to Host Research and Development Day on November 20, 2015Printer Friendly Version
11/02/15Proteon Therapeutics Completes Enrollment in PATENCY-1, First Phase 3 Clinical Study of Investigational VonapanitasePrinter Friendly Version
10/28/15Proteon Therapeutics to Present at the BIO-Europe 2015 Conference November 3Printer Friendly Version
10/19/15Proteon Therapeutics Appoints Tony Kingsley to Its Board of DirectorsPrinter Friendly Version
10/12/15Proteon Therapeutics Announces Results from Phase 1 Study of Investigational Drug Vonapanitase in Patients with Symptomatic Peripheral Artery Disease Presented at TCT 2015Printer Friendly Version
09/02/15Proteon Therapeutics to Present at Two Upcoming Investor ConferencesPrinter Friendly Version
09/01/15Proteon Therapeutics Appoints Jennifer Panagoulias as Vice President of Regulatory AffairsPrinter Friendly Version
08/13/15Proteon Therapeutics Announces Second Quarter 2015 Financial ResultsPrinter Friendly Version
08/13/15Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery DiseasePrinter Friendly Version
08/12/15Proteon Therapeutics Initiates Second Phase 3 Clinical Study of Investigational Drug VonapanitasePrinter Friendly Version
07/22/15Proteon Therapeutics Appoints Scott Canute to Its Board of DirectorsPrinter Friendly Version
06/29/15Proteon Therapeutics Announces Addition to Russell 2000 IndexPrinter Friendly Version
06/17/15Proteon Therapeutics to Present at the JMP Securities Life Science Conference June 24thPrinter Friendly Version
06/02/15Proteon Therapeutics Appoints Scott Toner as Senior Vice President of MarketingPrinter Friendly Version
05/22/15Proteon Therapeutics to Present at Upcoming ERA-EDTA Annual CongressPrinter Friendly Version
05/13/15Proteon Therapeutics Announces First Quarter 2015 Financial ResultsPrinter Friendly Version
04/13/15Proteon Therapeutics to Present at Two International Vascular Access ConferencesPrinter Friendly Version
03/26/15Proteon Therapeutics Announces Positive Long-Term Results From Phase 2 Study of Investigational New Drug Vonapanitase in Chronic Kidney Disease Patients Undergoing Surgical Creation of an Arteriovenous Fistula for HemodialysisPrinter Friendly Version
03/20/15Proteon Therapeutics Announces Fourth Quarter and Full-Year 2014 Financial ResultsPrinter Friendly Version
02/26/15Proteon Therapeutics to Present at the Cowen and Company 35th Annual Healthcare Conference on March 4thPrinter Friendly Version
02/06/15Proteon Therapeutics to Ring the Nasdaq Stock Market Opening Bell on February 9thPrinter Friendly Version
02/05/15Proteon Therapeutics to Present at the 17th Annual BIO CEO & Investor Conference February 9thPrinter Friendly Version
01/08/15Journal of Cardiovascular Pharmacology Publishes Positive Nonclinical Results of Proteon Therapeutics' PRT-201 in Peripheral Artery DiseasePrinter Friendly Version